Dottorato di ricerca in Ematologia

Informazioni generali

Denominazione del corso	Ematologia
Durata prevista	3 ANNI
Dipartimento	Dip. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI

Ambito

Settori scientifico disciplinari interessati	Aree interessate
MED/15 - MALATTIE DEL SANGUE	06 - Scienze mediche
BIO/13 - BIOLOGIA APPLICATA	05 - Scienze biologiche

Atenei italiani consorziati

Ateneo

Dipartimento/Facoltà

Sede dell'attività didattica

Atenei stranieri consorziati

Denominazione

Stato

Tipologia di Dottorato

Sede dell'attività didattica

Convenzione con soggetti (enti/organizzazioni/istituzioni)

n.	Tipologia del soggetto	Denominazione del soggetto	Denominazione nuovo soggetto
1.	Ospedali/ASL	Policlinico Tor Vergata

Obiettivi formativi

Il Dottorato di Ricerca in Ematologia si propone di formare ricercatori in grado di approfondire in maniera autonoma e scientificamente corretta gli aspetti clinico-biologici delle principali patologie neoplastiche del sistema emolinfopoietico (leucemie acute e croniche, linfomi maligni, discrasie plasmacellulari). Quattro sono i principali indirizzi formativi offerti: diagnostica e caratterizzazione biologica delle neoplasie ematologiche; strategie terapeutiche innovative nelle neoplasie ematologiche; biotecnologia e clinica del trapianto di cellule staminali emolinfopoietiche autologhe; biotecnologia e clinica del trapianto di cellule staminali emolinfopoietiche allogeniche. La formazione è basata inizialmente su una fase propedeutica di orientamento in cui i Dottorandi vengono introdotti, attraverso una serie coordinata di lezioni e seminari dedicati, alle tematiche di ricerca portate avanti dai vari gruppi che afferiscono al Dottorato. Successivamente, sotto la supervisione di un Tutor designato il Dottorando è chiamato a sviluppare un progetto autonomo di ricerca il cui stato di avanzamento verrà sottoposto a verifiche annuali da parte del Consiglio dei Docenti. Il conferimento del titolo di Dottore di Ricerca è subordinato alla presentazione e discussione dei risultati ottenuti da pubblicare su riviste indicizzate nell’area della Ematologia.

Tematiche di ricerca

1.	1) Diagnostica e Caratterizzazione Biologica delle neoplasie Ematologiche
2.	2) Strategie Terapeutiche intensive nelle Neoplasie Ematologiche
3.	3) Trapianto di Cellule Staminali Emopoietiche Autologhe
4.	4) Trapianto di Cellule Staminali Emopoietiche Allogeniche.

Coordinatore responsabile

Cognome	AMADORI
Nome	Sergio
Ateneo	Università degli Studi di ROMA "Tor Vergata"
Dipartimento	Dip. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI
Ruolo	Prof. ordinario
Settore	MED/15

Partecipanti il collegio (personale di ruolo nelle università italiane)

n.	Cognome	Nome	Ateneo	Dipartimento	Ruolo	Settore
1.	AMADORI	Sergio	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	PO	MED/15
2.	ARCESE	William	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	PA	MED/15
3.	BUCCISANO	Francesco	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	RU	MED/15
4.	CANTONETTI	Maria	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	PA	MED/15
5.	CIMINO	Giuseppe	Università degli Studi di ROMA "La Sapienza"	DIP. BIOTECNOLOGIE CELLULARI ED EMATOLOGIA	RU	MED/15
6.	CUDILLO	Laura	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	RU	MED/15
7.	DE FABRITIIS	Paolo	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	PA	MED/15
8.	LO COCO	Francesco	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	PA	MED/15
9.	PICARDI	Alessandra	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	RU	MED/15
10.	VENDITTI	Adriano	Università degli Studi di ROMA "Tor Vergata"	DIP. BIOPATOLOGIA E DIAGNOSTICA PER IMMAGINI	PA	MED/15

Personale appartenente ad Università Straniere

n.

Cognome

Nome

Struttura

Dipartimento

Ruolo

Settore

Partecipanti il collegio (personale non di ruolo nelle università o dipendente di altri enti)

n.

Cognome

Nome

Struttura

Dipartimento

Ruolo

Settore

Requisiti richiesti per l'ammissione

VECCHIO ORDINAMENTO: Tutte le lauree	NO
Se non tutte consentono l'accesso, indicare quelle che lo consentono	Medicina e Chirurgia; Scienze Biologiche
NUOVO ORDINAMENTO: Tutte le lauree	NO
Se non tutte consentono l'accesso, indicare quelle che lo consentono	6/S ( in biologia), 46/S ( in medicina e chirurgia)
Altro per studenti stranieri	Dichiarazione di Valore; Equipolenza della Laurea alle Lauree Vecchio Ordinamento o Specialistiche.
Altro

Modalità di ammissione

Analisi titoli,
Prova scritta,
Orale,
Lingua

Per i candidati stranieri (se diversa da quella per i candidati italiani)

Analisi titoli,
Orale,
Lingua

Attività

Attività didattica prevista	SI	Obbligatorio
-Insegnamenti previsti nell'iter formativo	tot CFU	n.ro insegnamenti  10
-Insegnamenti mutuati da corsi di laurea	NO	n.ro
Cicli seminariali	SI	n.ro  30
Verifiche annuali previste	SI	n.ro  3
Numero totale delle verifiche	3
Stage presso	Istituzione scientifica straniera, Irccs, Ospedali/ASL
Soggiorni all'estero	SI	Non Obbligatorio
-Periodo consentito all'estero (in mesi)	min:  1	max:  24
-Finalità del soggiorno all'estero	Attività di ricerca, Attività relative alla tesi

Produzione scientifica del collegio dal 1999 al 2004 (personale di ruolo nelle università italiane)

1.	A MENGARELLI, A P IORI, A ROMANO, R CERRETTI, C GUGLIELMI, L CERILLI, S DE PROPRIS, S FENU, M L MOLETI, L DE FELICE, G GIRELLI, ARCESE W. (2003). One-Year Cyclosporine Prophylaxis Reduces The Risk Of Developing Extensive Chronic Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation. HAEMATOLOGICA. vol. 88, pp. 315-323.
2.	A MENGARELLI, AP IORI, R CERRETTI, L CERILLI, ARCESE W. (2002). Increasing risk of relapse after Allogeneic Stem Cell Transplant for Adult Acute Lymphoblastic Leukemia in ≥ 2nd Complete Remission Induced by Highly Intensive Chemotherapy. HAEMATOLOGICA. vol. 87, pp. 782-784.
3.	A TESTI, I DEL GIUDICE, ARCESE W., ML MOLETI, F GIONA, G BASSO, A BIONDI, V CONTER, C MESSINA, R RONDELLI, A MICOZZI, C MICALIZZI, E BARISONE, F LOCATELLI, G DINI, M ARIC, F CASALE, M COMIS, S LADOGANA, A LIPPI, ROSSELLA MURA, MF PINTA, N SANTORO, MG VALSECCHI, G MASERA AND F MANDELLI. (2002). A single high dose of Idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood “higk-risk” acute lymphoblastic leukaemia: a study of the AIEOP group. BRITISH JOURNAL OF HAEMATOLOGY. vol. 118, pp. 741-747.
4.	A. BACIGALUPO, B. BRUNO, P. SARACCO, E. DI BONA, A. LOCASCIULLI, F. LOCATELLI, A. GABBAS, C. DUFOUR, ARCESE W., A.M. TESTI, G. BROCCIA, M. CAROTENUTO, P. COSER, T. COMOTTI, P. LEONI, A. FERSTER FOR THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION EBMT WORKING PARTY ON SAA. (2000). Antilymphocyte globulin, cyclosporine, prednisolone,and granulocyte colony- stimulating factor (G-CSF) for severe aplastic anemia (SAA): An update of the GITMO/EBMT Study on 100 patients. BLOOD. vol. 95, pp. 1931-1934.
5.	A. MENGARELLI, A.P. IORI, C.GUGLIELMI, A. ROMANO, R. CERRETTI, C. TORROMEO, A. MICOZZI, S. FENU, L. LAURENTI, V. DONATO, ARCESE W. (2002). Standard vs Alternative Myeloablative Conditioning Regimens in Allogeneic Haematopoietic Stem Cell Transplant for High-risk Acute Leukaemia. HAEMATOLOGICA. vol. 87, pp. 52-58.
6.	A. MENGARELLI, A.P. IORI, C.GUGLIELMI, M.P. PERRONE, M. GOZZER, C. GIRMENIA, G. CIMINO, A.M. TESTI, R. RICCI, L. DE FELICE, G. GIRELLI, ARCESE W. (2000). Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies. LEUKEMIA. vol. 14, pp. 2052-2058.
7.	A. MENGARELLI, C. MINOTTI, G. PALUMBO, P. ARCIERI, G. GENTILE, A.P. IORI, ARCESE W., F. MANDELLI AND G. AVVISATI. (2000). High levels of antiphospholipid antibodies are associated to CMV infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation. BRITISH JOURNAL OF HAEMATOLOGY. vol. 108, pp. 126-131.
8.	A. VENDITTI, A. TAMBURINI, F. BUCCISANO, M.T. SCIM, G. DEL POETA, L. MAURILLO, M.C. COX, E. ABRUZZESE, M. TRIBALTO, M. MASI, AMADORI S. (2000). A phase II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment og high-risk myelodysplastic syndromes. ANNALS OF HEMATOLOGY. vol. 79, pp. 138-142.
9.	A. VENDITTI, F. BUCCISANO, G. DEL POETA, L. MAURILLO, A. TAMBURINI, C. COX, A. BATTAGLIA, G. CATALANO, B. DEL MORO, L. CUDILLO, M. POSTORINO, M. MASI, AMADORI S. (2000). Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. BLOOD. vol. 96, pp. 3948-3952.
10.	A. VENDITTI, G. DEL POETA, L. MAURILLO, F. BUCCISANO, M.I. DEL PRINCIPE, C. MAZZONE, A. TAMBURINI, C. COX, P. PANETTA, B. NERI, L. OTTAVIANI, AMADORI S. (2004). Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia. HAEMATOLOGICA. vol. 89, pp. 934-939.
11.	A.BRUNO, T.CARAVITA, G.ADORNO, G.DEL POETA, VENDITTI A., R.STASI, G.BALLATORE, G.DEL PROPOSTO, A.LANTI, F.ZINNO, L.CUDILLO, T.DENTAMARO, F.BUCCISANO, A.TAMBURINI, S.SANTINELLI, L.MAURILLO, M.CANTONETTI, M.C.COX, M.MASI, G.CATALANO, G.ISACCHI, S.AMADORI. (2002). Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors. TRANSFUSION AND APHERESIS SCIENCE. vol. 26, pp. 103-110.
12.	A.LOCASCIULLI, ARCESE W., F. LOCATELLI, E. DI BONA, A. BACIGALUPO, FOR THE ITALIAN APLASTIC ANEMIA STUDY GROUP. (2001). Treatment of aplastic anaemia with granulocyte-colony stimulating factor (G-CSF) and risk of malignancy. LANCET. vol. 357, pp. 43-44.
13.	A.PICARDI, P. DE FABRITIIS, L. CUDILLO, T. DENTAMARO, L. CUPELLI, G. BALLATORE, A. VENDITTI, T. CARAVITA, M.C. COX, AMADORI S. (2004). Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation. HEMATOLOGY JOURNAL. vol. 5, pp. 24-31.
14.	A.VENDITTI, A.TAMBURINI, BUCCISANO F., M.T.SCIM, G.DEL POETA, L.MAURILLO, M.C.COX, E.ABRUZZESE, M.TRIBALTO, M.MASI, S.AMADORI. (2000). A phase II clinical trial of all trans retinoic acid and low dose cytosine arabinoside for the treatment of high risk myelodysplastic syndromes. ANNALS OF HEMATOLOGY. vol. 79, pp. 138-142.
15.	A.VENDITTI, G.DEL POETA, A.BATTAGLIA, BUCCISANO F., A.TAMBURINI, L.MAURILLO, T.CARAVITA, B.DEL MORO, AM.EPICENO, A.PICARDI, M.POSTORINO, M.MARTIRADONNA, S.SANTINELLI, G.ADORNO, F.ZINNO, A.LANTI, A.BRUNO, G.SUPPO, A.FRANCHI, S.AMADORI. (1999). Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods. BONE MARROW TRANSPLANTATION. vol. 24, pp. 1019-1027.
16.	A.VENDITTI, L.MAURILLO, F.BUCCISANO, G.DEL POETA, C.MAZZONE, A.TAMBURINI, M.I.DEL PRINCIPE, M.I.CONSALVO, P.DE FABRITIIS, L.CUDILLO, A.PICARDI, A.FRANCHI, F. LO COCO, AMADORI S. (2003). Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation. LEUKEMIA. vol. 17, pp. 2178-2182.
17.	ABRUZZESE E, CANTONETTI M., MORINO L, ORLANDI G, TENDAS A, DEL PRINCIPE MI, MASI M, AMADORI S, ORLANDI A, ANEMONA L, CAMPIONE E. (2003). CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case report. JOURNAL OF CLINICAL ONCOLOGY. vol. 21, pp. 4256-4258.
18.	ABRUZZESE E, RADFORD JE, MILLER JS, VREDENBURGH JJ, RAO PN, PETTENATI MJ, CRUZ JM, AMADORI S., HURD DD. (1999). Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation. BLOOD. vol. 94, pp. 1814-1819.
19.	AGLIETTA M, MONTEMURRO F, FAGIOLI F, VOLTA C, BOTTO B, CANTONETTI M., RACANELLI V, TEOFILI L, FERRARA R, AMADORI S, DAMMACCO F, LEVIS A. (2000). Short-term treatment with Ecoli recombinant human granulocyte-macrophage colony stimulating factor prior to chemotherapy for Hodgkin’s disease. CANCER. vol. 88(2), pp. 454-460.
20.	AGOSTINI F., DE FELICE L., RAPANOTTI MC., MASCOLO MG., IORI AP., TESTI AM., MENGARELLI A., PIGNOLONI P., CIMINO G., SCRENCI M., MANDELLI F., ARCESE W. (2001). In vitro kinetic of hematopoietic and stromal cell reconstitution after unrelated cord blood and bone marrow transplant. HAEMATOLOGICA.
21.	ALESSANDRINO EP, AMADORI S., CAZZOLA M, LOCATELLI F, MECUCCI C, MORRA E, SAGLIO G, VISANI G, TURA S. (2001). Myelodysplastic syndromes: recent advances. HAEMATOLOGICA. vol. 86, pp. 1124-1157.
22.	ALEXANDER FE, PATHEAL SL, BIONDI A, BRANDALISE S, CABRERA ME, CHAN LC, CHEN Z, CIMINO G., CORDOBA JC, GU LJ, HUSSEIN H, ISHII E, KAMEL AM, LABRA S, MAGALHAS IQ, MIZUTANI S, PETRIDOU E, DE OLIVERA MP, YUEN P, WIEMELS JP, GREAVES MF. (2001). Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. CANCER RESEARCH. vol. 61, pp. 2542-2546.
23.	AMADORI S., S. SUCIU, R. WILLEMZE, F. MANDELLI, D. SELLESLAG, R. STAUDER, A. HO, C. DENZLINGER, G. LEONE, P. FABRIS, P. MUUS, M. VIGNETTI, A. HAGEMEIJER, F. BEELDENS, O. ANAK, T. DE WITTE. (2004). Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. HAEMATOLOGICA. vol. 89, pp. 950-956.
24.	ANNA LOCASCIULLI, BARBARA BRUNO, E. PAOLO ALESSANDRINO, GIOVANNA MELONI, WILLIAM ARCESE, GIUSEPPE BANDINI, VINCENZO CASSIBBA, BRUNO ROTOLI, ENRICA MORRA, IGNAZIO MAJOLINO, ARCESE W. (2003). Hepatitis Reactivation And Liver Failure In Hemopoietic Stem Cell Transplants For Hepatitis B Virus (Hbv) / Hepatitis C Virus (Hcv) Positive Recipients: A Retrospective Study By The Italian Group For Blood And Marrow Transplantation-Gitmo. BONE MARROW TRANSPLANTATION. vol. 31, pp. 295-300.
25.	ANNA PAOLA IORI, RAFFAELLA CERRETTI, LIDIA DE FELICE, MARIA SCRENCI, ANDREA MENGARELLI, ATELDA ROMANO, MAURIZIO CANIGLIA, LORENZA CERILLI, GIUSEPPE GENTILE, MARIA LUISA MOLETI, FIORINA GIONA, FRANCESCA AGOSTINI, IRENE PASQUA, MARIA PAOLA PERRONE, MARIA RITA PINTO, LAVINIA GRAPULIN, ANNA MARIA TESTI, PIETRO MARTINO, GIULIO DE ROSSI, ARCESE W. (2004). Pre-Transplant Prognostic Factors for Patients with High-risk Leukemia undergoing an Unrelated Cord Blood Transplantation. BONE MARROW TRANSPLANTATION. vol. 33, pp. 1097-1105.
26.	ANNINO L., VEGNA M.L., CAMERA A., SPECCHIA G., VISANI G., FIORITONI G., FERRARA F., PETA A., CIOLLI S., DEPLANO W., FABBIANO F., SICA S., DI RAIMONDO F., CASCAVILLA N., TABILIO A., LEONI P., INVERNIZZI R., BACCARANI M., ROTOLI B., AMADORI S., MANDELLI F. (2002). Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. BLOOD. vol. 99, pp. 863-871.
27.	ANSELMO AP, CAVALIERI E, MELONI G, ALIMENA G, CANTONETTI M., MAURIZI ENRICI R, TOSTI ME, FALCHETTO OSTI M, GIANFELICI V, MANDELLI F. (2002). Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease. HAEMATOLOGICA. vol. 87, pp. 507-511.
28.	AP IORI, R CERRETTI, A ROMANO, ARCESE W. (2002). Il Trapianto Allogenico di Cellule Staminali Ematopoietiche da Donatore Familiare HLA compatibile nel Mieloma Multiplo. I Conferenza Nazionale sul Mieloma. (pp. 173-181).
29.	ARCESE W., A.P. IORI, L. DE FELICE. (2000). Il Trapianto di Cellule Staminali Emopoietiche da Sangue di Cordone Ombelicale. Oncology and Hematology Review. (vol. 4, pp. 10-20).
30.	ARCESE W., C. GUGLIELMI. (2000). Survival of patients with Ph+ chronic myeloid leukemia relapsing after an allogeneic stem cell transplant. HAEMATOLOGICA. vol. 85, pp. 3-4.
31.	ARCESE W., IORI AP., DE FELICE L. (2000). Il trapianto di cellule staminali emopoietiche da sangue di cordone ombelicale. (vol. 4, pp. 10-20). Oncology & Hematology Review.
32.	ARCESE W., TERENZI A., MASCOLO MG., AGOSTINI F., FALZETTI F., SCRENCI M., DI IANNI M., PASQUALETTI D., TABILIO A., DE FELICE L. (2002). Kinetic of engraftment in NOD/SCID mice transplanted with ex-vivo short-term culture amplified human cord blood cells. A model for clinical setting. New perspectives in allogeneic transplantation of hematopoietic cells. (pp. 39-46). 2nd EBMT workshop.
33.	ARCHIMBAUD E, JEHN U, THOMAS X, DE CATALDO F, FILLET G, BELHABRI A, PEAUD PY, MARTIN C, AMADORI S., WILLEMZE R. (1999). Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia. LEUKEMIA. vol. 13, pp. 843-849.
34.	BACIGALUPO A., BRUNO B., SARACCO P., DI BONA E., LOCASCIULLI A., LOCATELLI F., GABBAS C., DUFOUR C., ARCESE W., TESTI AM., BROCCIA G., CAROTENUTO M. (2000). Antilymphocyte globulin, cyclosporine, prednisolone and granulocyte colony-stimulating factor (G-CSF) for severe aplastic anemia (SAA): an update of the GITMO7EBMT study on 100 patients. BLOOD. vol. 95, pp. 1931-1934.
35.	BELLUCCI R, DE PROPRIS MS, BUCCISANO F, LISCI A, LEONE G, TABILIO A, DE FABRITIIS P. (1999). Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF. BONE MARROW TRANSPLANTATION. vol. 23(1), pp. 1-8.
36.	BELLUCCI R, SALA R, DE PROPRIS MS, CORDONE I, DE FABRITIIS P. (1999). Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma. LEUKEMIA & LYMPHOMA. vol. 35(5-6), pp. 471-481.
37.	BIONDI A, CIMINO G., PETERS R, PUI CH. (2000). Biological and therapeutic insight of infant leukemia. BLOOD. vol. 96, pp. 24.
38.	BUCCISANO F., ROSSI FM, VENDITTI A, DEL POETA G, COX MC, ABBRUZZESE E, RUPOLO M, BERRETTA M, DEGAN M, RUSSO S, TAMBURINI A, MAURILLO L, DEL PRINCIPE MI, POSTORINO M, AMADORI S, GATTEI V. (2004). CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias. BRITISH JOURNAL OF HAEMATOLOGY. vol. 125, pp. 203-212.
39.	C. GIRMENIA, A.P. IORI, S. BERNASCONI, A.M. TESTI, M.L. MOLETI, ARCESE W., P. MARTINO. (2000). Listeriosis in Unrelated Donor Allogeneic Bone Marrow Transplant Recipients. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. vol. 19, pp. 711-714.
40.	C. GUGLIELMI, ARCESE W., F. DAZZI, R. BRAND, D. BUNJES, L.F. VERDONCK, A. SCHATTENBERG, H-J. KOLB, P. LJUNGMAN, A. DEVERGIE, A. BACIGALUPO, M. GOMEZ, M. MICHALLET, A. ELMAAGACLI, A. GRATWOHL, J. APPERLEY AND D. NIEDERWIESER ON BEHALF OF THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION. (2002). Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. BLOOD. vol. 100, pp. 397-405.
41.	C. GUGLIELMI, ARCESE W., J. HERMANS, A. BACIGALUPO, G. BANDINI, D. BUNJES, E. CARRERAS, A. DEVERGIE, F. FRASSONI, J. GOLDMAN, A. GRATWOHL, H-J. KOLB, A.P. IORI, D. NIEDERWIESER, H.G. PRENTICE, T. DE WITTE, AND J. APPERLEY ON BEHALF OF THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION. (2000). Risk Assessment in Patients with Ph+Chronic Myelogenous Leukemia at First Relapse after Allogeneic Stem Cell Transplant. An EBMT Retrospective Analysis. BLOOD. vol. 95, pp. 3328-3334.
42.	CANTONETTI M., ITALIAN COOPERATIVE GROUP ON CHRONIC MYELOID LEUKEMIA. (1999). Monitoring treatment and survbival in Cronic Myeloid Leukemia. JOURNAL OF CLINICAL ONCOLOGY. vol. 17(6), pp. 1858-1868.
43.	CARAVITA T, BRUNO A, ADORNO G, SANTINELLI S, SINISCALCHI A, ABRUZZESE E, PALOMBI F, TAMBURINI A, BALLATORE G, CUDILLO L., AMADORI S, DEL PROPOSTO G, ISACCHI G. (2003). Low cell concentration of cryopreserved autologous CD34+ peripheral blood progenitor cells does not impair hematopoietic recovery after transplantation. TRANSFUSION AND APHERESIS SCIENCE.
44.	CHESON B., BENNET JM., KOPECKY KJ., BUCHNER T., WILLMAN CL., ESTEY E., SCHIFFER CA., DOEHNER H., TALLMAN MS., LISTER TA., LO COCO F., ET AL. (2003). Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. JOURNAL OF CLINICAL ONCOLOGY. vol. 21, pp. 4642-4649.
45.	CIMINO G., ELIA L, MANCINI M, ANNINO L, ET AL. (2003). Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. BLOOD. vol. 102, pp. 2014-2020.
46.	CIMINO G., ELIA L, RAPANOTTI MC, SPROVIERI T, MANCINI M, CUNEO A, MECUCCI C, FIORITONI G, CAROTENUTO M, MORRA E, LISO V, ANNINO L, SAGLIO G, DE ROSSI G, FOA' R, MANDELLI F. (2000). A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic disease. BLOOD. vol. 95, pp. 96-101.
47.	CIMINO G., RAPANOTTI MC, ELIA L, IORI AP, GUGLIELMI C, SCRENCI M, CARMINI D, DE FELICE L, MOLETI ML, MENGARELLI A, MANDELLI, W ARCESE. (1999). A prospective molecular study of chimerism in patients with hematologic malignancies receiving unrelated cord blood or bone marrow transplants: detection of meixed chimerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. BRITISH JOURNAL OF HAEMATOLOGY. vol. 104, pp. 700.
48.	COX M.C., SCANZANI A., DEL POETA G., VENDITTI A., PANETTA P, DERME V., SGRO R., MASI M., AMADORI S. (2000). A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0). CANCER GENETICS AND CYTOGENETICS. vol. 118, pp. 76-79.
49.	COX MC, PANETTA P, LO-COCO F, DEL POETA G, VENDITTI A., MAURILLO L, DEL PRINCIPE MI, MAURIELLO A, ANEMONA L, BRUNO A, MAZZONE C, PALOMBO P, AMADORI S. (2004). Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. AMERICAN JOURNAL OF CLINICAL PATHOLOGY. vol. 122(2), pp. 298-306.
50.	COX MC, PANETTA P, VENDITTI A, ABRUZZESE E, DEL POETA G, CANTONETTI M, AMADORI S. (2001). New reciprocal translocation t(6;10)(q27;q11) associated with idiopathic myelofibrosis and eosinophilia. LEUKEMIA RESEARCH. vol. 25, pp. 349-351.
51.	COX MC, PANETTA P, VENDITTI A, DEL POETA G, FRANCHI A, BUCCISANO F., TAMBURINI A, MAURILLO L, AMADORI S. (2003). Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients. HEMATOLOGY JOURNAL. vol. 4, pp. 263-270.
52.	DE FABRITIIS P, DENTAMARO T, PICARDI A, CUDILLO L., MASI M, AMADORI S. (2004). recombinant factor VIIa for the management of severe hemorrhages patients with hematologic malignancies. HAEMATOLOGICA. vol. 89, pp. 243-245.
53.	DE FABRITIIS P., GONZALEZ M, MELONI G, DE PROPRIS MS, BELLUCCI R, CORDONE I, GOZZER M, LEONE G, MANDELLI F. (1999). Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells. BONE MARROW TRANSPLANTATION. vol. 23(12), pp. 1229-1236.
54.	DE FABRITIIS P., IORI AP, MENGARELLI A, GOZZER M, FERRAZZA G, DE PROPRIS MS, ROMANO A, ARCESE W. (2001). CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF. TRANSFUSION. vol. 41(2):-, pp. 190-195.
55.	DE FELICE L., CIMINO G., AGOSTINI F., MASCOLO MG., RAPANOTTI MC., PIGNOLONI P., IORI AP., MENGARELLI A., TESTI AM., SCRENCI M., MANDELLI F., ARCESE W. (2001). Hematopoietic and stromal cell reconstitution after unrelated cord blood and bone marrow transplant. BONE MARROW TRANSPLANTATION. vol. 27, Suppl. 1, pp. S100.
56.	DE FELICE L., TERENZI A., MASCOLO MG., AGOSTINI F., FALZETTI F., DI IANNI M., PASQUALETTI D., SIMONE F., AMARANTO P., TABILIO A., ARCESE W. (2002). Human engraftment of ex-vivo amplified cord blood cells in NOD/SCID mice is improved by accessory cells. VII congresso della Società Italiana di Ematologia Sperimentale.
57.	DE FELICE L., TERENZI A., MASCOLO MG., AGOSTINI F., FALZETTI F., PASQUALETTI D., DI IANNI M., TABILIO A., ARCESE W. (2001). early and late engraftment of short-term ex-vivo amplified cord blood cells in NOD/SCID mice. BONE MARROW TRANSPLANTATION. vol. 27, Suppl. 1, pp. S99-100.
58.	DE FELICE L., TERENZI A., MASCOLO MG., AGOSTINI F., FALZETTI F., TABILIO A., ARCESE W. (2000). Early engraftment of short-term ex-vivo amplified cord blood cells in NOD/SCID mice. HAEMATOLOGICA. vol. 85, Suppl. 9, pp. 49.
59.	DE PROPRIS MS, MELONI G, CORDONE I, CAPRIA S, BELLUCCI R, TRISOLINI S, SIMONE F, DE FABRITIIS P. (2003). Possibility of progenitor cell mobilization during the hematological recovery following peripheral blood stem cell autograft. ACTA HAEMATOLOGICA. vol. 109(2), pp. 57-63.
60.	DE WITTE T., SUCIU S., VERHOEF G., LABAR B., ARCHIMBAUD E., AUL C., SELLESLAG D., FERRANT A., WIJERMANS P., MANDELLI F., AMADORI S., JEHN U., MUUS P., BOOGAERTS M., ZITTOUN R., GRATWOHL A., ZWIERZINA H., HAGEMEIJER A, WILLEMZE R. (2001). Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS. BLOOD. vol. 98, pp. 2326-2331.
61.	DEL POETA G, VENDITTI A, DEL PRINCIPE MI, MAURILLO L, BUCCISANO F., TAMBURINI A, COX MC, FRANCHI A, BRUNO A, MAZZONE C, PANETTA P, SUPPO G, MASI M, AMADORI S. (2003). Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia. BLOOD. vol. 101, pp. 2125-2131.
62.	DEL POETA G, VENDITTI A, STASI R, ARONICA G, COX MC, BUCCISANO F, TAMBURINI A, BRUNO A, MAURILLO L, BATTAGLIA A, SUPPO G, EPICENO AM, DEL MORO B, MASI M, AMADORI S., PAPA G. (1999). P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia. LEUKEMIA RESEARCH. vol. 23, pp. 451-465.
63.	DEL PRINCIPE MI, DEL POETA G, MAURILLO L, BUCCISANO F, VENDITTI A, TAMBURINI A, BRUNO A, COX MC, SUPPO G, TENDAS A, GIANNI L, POSTORINO M, MASI M, DEL PRINCIPE D, AMADORI S. (2003). P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY. vol. 121, pp. 730-738.
64.	E. GLUCKMAN, V. ROCHA, W. ARCESE, G. MICHEL, G. SANZ, K.W. CHAN, T.A. TAKAHASHI, J. ORTEGA, A. FILIPOVICH, F. LOCATELLI, S. ASANO, F. FAGIOLI, M. VOWELS, A. SIRVENT, J.P. LAPORTE, K. TIEDEMANN, AMADORI S., M. ABECASSIS, P. BORDIGONI, B. DIEZ, P.J. SHAW, A. VORA, M. CANIGLIA, F. GARNIER, I. IONESCU, J. GARCIA, G. KOEGLER, P. REBULLA, S. CHEVRET. (2004). Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. EXPERIMENTAL HEMATOLOGY. vol. 32, pp. 397-407.
65.	ELIA E, MANCINI M, MOLETI L, MELONI G, BUFFOLINO S, KRAMPERA M, DE ROSSI G, FO R, CIMINO G. (2003). A nultiplex reverse transcription-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. HAEMATOLOGICA. vol. 88, pp. 275-279.
66.	F BONIFAZI, G BANDINI, ARCESE W. (2002). Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow transplantation. HAEMATOLOGICA. vol. 87, pp. 449-452.
67.	F. FRASSONI, M. LABOPIN, R.L. POWLES, J-Y MARY, ARCESE W., A. BACIGALUPO, D. BUNJES, E. GLUCKMAN, T. RUUTU, U.W. SCHAEFER, J. SIERRA, J.P. VERNANT, R. WILLEMZE, T. DE WITTE AND N.C. GORIN FOR THE ACUTE LEUKAEMIA WORKING PARTY OF THE EBMT. (2000). Effect of Centre on Outcome of Bone-Marrow Transplantation for Acute Myeloid Leukaemia. LANCET. vol. 355, pp. 1393-1398.
68.	F.FERRARA, VENDITTI A., A.M.CARELLA, N.CANTORE, F.BUCCISANO, A.TAMBURINI, S.CALMIERI, G.MELE, M.ANNUNZIATA, M.M.GRECO, S.AMADORI. (2002). Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yr. EUROPEAN JOURNAL OF HAEMATOLOGY. vol. 69, pp. 200-204.
69.	FALINI B, MECUCCI C, TIACCI E, ALCALAY M, ROSATI R, PASQUALUCCI L, LA STARZA R, DIVERIO D, COLOMBO E, SANTUCCI A, BIGERNA B, PACINI R, PUCCIARINI A, LISO A, VIGNETTI M, FAZI P, MEANI N, PETTIROSSI V, SAGLIO G, MANDELLI F, LO COCO F., PELICCI PG, MARTELLI MF. (2004). Cytoplasmic Nucleophosmin (NPM) Identifies a Subtype of Acute Myelogenous Leukemia With A Normal Karyotype and NPM Gene Mutations. NEW ENGLAND JOURNAL OF MEDICINE. in corso di stampa.
70.	FARGNOLI MC, PERIS K, FRANCESCONI F, CANTONETTI M., CERRONI L, CHIMENTI S. (2002). Granulomatous mycosis fungoides responsive to gemcitabine. EUROPEAN JOURNAL OF DERMATOLOGY. vol. 12, pp. 479-481.
71.	FERRARA F, VENDITTI A, CARELLAJR AM, CANTORE N, BUCCISANO F., TAMBURINI A, PALMIERI S, MELE G, ANNUNZIATA M, GRECO MM, AMADORI S. (2002). Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yr. EUR J HEMATOL. vol. 69, pp. 200-204.
72.	FERRARA F.F., FAZI F., BIANCHINI A., PADULA F., GELMETTI V., MINUCCI S., MANCINI M., PELICCI P.G., LO COCO F., NERVI C. (2001). Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. CANCER RESEARCH. vol. 61, pp. 2-.
73.	FIANCHI L, PICARDI M, CUDILLO L., CORVATTA L, MELE L, TRAPE G, GIRMENIA C, PAGANO L. (2004). Aspergillus niger infection in patients with haematological diseases: a report of eight cases. MYCOSES. vol. 47, pp. 163-167.
74.	FRANCESCO LO COCO, ATELDA ROMANO, ANDREA MENGARELLI, DANIELA DIVERIO, ANNA PAOLA IORI, MARIA LUISA MOLETI, SILVIA DE SANTIS, RAFFAELLA CERRETTI, FRANCO MANDELLI, ARCESE W. (2003). Allogeneic Stem Cell Transplantation For Advanced Acute Promyelocytic Leukemia: Results In Patients Treated In 2ND Molecular Remission Or With Molecularly Persistent Disease. LEUKEMIA. vol. 17, pp. 1930-1933.
75.	G DINI, R CANCEDDA, G GIORGIANI, F PORTA, C MESSINA, C UDERZO, A PESSION, F FAGIOLI, G LA NASA, ARCESE W., S POLLICHIENI, M ZECCA, E LANINO, E MAZZOLARI, S CESARO, A BALDUZZI, R RONDELLI, E VASSALLO, B CAPPELLI, F LOCATELLI, ON BEHALF OF THE AIEOP AND THE GITMO. (2002). Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). HAEMATOLOGICA. vol. 87, pp. 47-53.
76.	G. DINI, R. CANCEDDA, F. LOCATELLI, A. BOSI, G. BANDINI, E. P. ALESSANDRINO, F. PORTA, C. UDERZO, C. MESSINA, F. FAGIOLI, ARCESE W., P. MARENCO, R. FANIN, M. FALDA, D. SOLIGO, G. LA NASA, C. GIARDINI, A. PESSION, R. SCIM, P. DI BARTOLOMEO, B. BRUNO, L. GARBARINO, T. LAMPARELLI, G. GIORGIANI, E. LANINO, C. MANZITTI, A. BACIGALUPO, FOR THE GITMO. (2000). Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO). HAEMATOLOGICA. vol. 86, pp. 30-36.
77.	G. DINI, R. CANCEDDA, F. LOCATELLI, A. BOSI, G. BANDINI, E. P. ALESSANDRINO, F. PORTA, C. UDERZO, C. MESSINA, F. FAGIOLI, ARCESE W., P. MARENCO, R. FANIN, M. FALDA, D. SOLIGO, G. LA NASA, C. GIARDINI, A. PESSION, R. SCIM, P. DI BARTOLOMEO, B. BRUNO, L. GARBARINO, T. LAMPARELLI, G. GIORGIANI, E. LANINO, C. MANZITTI, A. BACIGALUPO, FOR THE GITMO. (2001). Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO). HAEMATOLOGICA. vol. 86, pp. 451-456.
78.	G. SCONOCCHIA, N.Y. COCOCCETTA, L. CAMPAGNANO, AMADORI S., B. IORIO, V. BOFFO, V. FERDINANDI, I. DEL PRINCIPE, D. ADORNO, C.U. CASCIANI. (2001). Subcutaneous administration of interleukin-2 triggers Fcgamma receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies. JOURNAL OF IMMUNOTHERAPY. vol. 24, pp. 374-383.
79.	G.DEL POETA, L.MAURILLO, VENDITTI A., F.BUCCISANO, A.M.EPICENO, G.CAPELLI, A.TAMBURINI, G.SUPPO, A.BATTAGLIA, M.I.DEL PRINCIPE, B.DEL MORO, M.MASI, AND S.AMADORI. (2001). Clinical significance of CD38 expression in chronic lymphocytic leukemia. BLOOD. vol. 98, pp. 2633-2639.
80.	G.DEL POETA, VENDITTI A., M.I. DEL PRINCIPE, L.MAURILLO, A.TAMBURINI, F.BUCCISANO, M.C.COX, A.FRANCHI, C.MAZZONE, P.PANETTA, G.SUPPO, M.MASI, S.AMADORI. (2003). The amount of spontaneous apoptosis as detected by bax/bcl-2 ratio predicts outcome in acute myeloid leukemia. BLOOD. vol. 101, pp. 2125-2131.
81.	GERARD MICHEL, VANDERSON ROCHA, SYLVIE CHEVRET, WILLIAM ARCESE, ANNA PAOLA IORI, KAH-WAH CHAN, ALEXANDRA FILIPOVICH, TSUNEO TAKAHASHI, MARCUS VOWELS, JUAN ORTEGA, PIERRE BORDIGONI, PETER SHAW, ISAAC YANIV, ALEXANDRA MACHADO, PEDRO PIMENTEL, FRANCA FAGIOLI, VICTORIA CASTEL, JEAN PIERRE JOUET, BLANCA DIEZ, EURIPEDES FERREIRA, RICARDO PASQUINI, JOSEPH ROSENTHAL, ERIC SIEVERS, CHIARA MESSINA, FEDERICO GARNIER, IRINA IONESCU, ARCESE W. (2003). Unrelated Cord Blood Transplantation for Childhood Acute Myeloid Leukemia. An Eurocord group analysis. BLOOD. vol. 102, pp. 4290-4297.
82.	GIORGIO DINI, MARIA GRAZIA VALSECCHI, CONCETTA MICALIZZI, ALESSANDRO BUSCA, ADRIANA BALDUZZI, WILLIAM ARCESE, SIMONE CESARO, ARCANGELO PRETE, MARCO RABUSIN, EVELINA MAZZOLARI, PAOLO DI BARTOLOMEO, NICOLETTA SACCHI, ANDREA PESSION, GIOVANNA GIORGIANI, EDOARDO LANINO, TERESA LAMPARELLI, CLAUDIO FAVRE, ALBERTO BOSI, CARLA MANZITTI, STEFANIA GALIMBERTI, ARCESE W. (2003). Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic lukemia in second remission. BONE MARROW TRANSPLANTATION. vol. 32, pp. 325-331.
83.	ILARIA DEL GIUDICE, ANNA PAOLA IORI, ANDREA MENGARELLI, ANNA MARIA TESTI, ATELDA ROMANO, RAFFAELLA CERRETTI, F. MACR, M. IACOBINI, ARCESE W. (2003). Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. ANNALS OF HEMATOLOGY. vol. 82, pp. 189-192.
84.	K CWYNARSKI, IAG ROBERTS, S IACOBELLI, A VAN BIEZEN, R BRAND, A DEVERGIE, JM VOSSEN JM, M ALJURF, ARCESE W., F LOCATELLI F, G DINI, D NIETHAMMER, D NIEDERWIESER, JF APPERLEY FOR THE PAEDIATRIC AND CHRONIC LEUKAEMIA WORKING PARTIES OF THE EBMT. (2003). Stem Cell Transplantation For Chronic Myeloid Leukemia In Children. BLOOD. vol. 102, pp. 1224-1231.
85.	KEATING S., DE WITTE T., SUCIU S., MANDELLI F., DAMASIO E.., WILLEMZE R., MORRA E., AMADORI S., DARDENNE M., VEGNA M.L., ZITTOUN R. (1999). Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMA. EUROPEAN JOURNAL OF CANCER. vol. 35, pp. 1440-1447.
86.	L.PAGANO, A.PULSIONI, M.VIGNETTI, L.MELE, L.FIANCHI, MC.PETTI, S.MIRTO, P.FALCUCCI, P.FAZI, G.BROCCIA, G.SPECCHIA, F.DI RAIMONDO, L.PACILLI, P.LEONI, S.LADOGANA, E.GALLO, VENDITTI A., G.AVANZI, A.CAMERA, V.LISO, G.LEONE, F.MANDELLI, FOR THE GIMEMA. (2002). Acute megakaryoblastic leukemia: experience of GIMEMA trials. LEUKEMIA. vol. 16, pp. 1622-1626.
87.	L.PAGANO, L.MELE, L.FIANCHI, S.RUTELLA, R.PISCITELLI, G.LEONE, A.PULSONI, P.DE FABRITIIS, R.FOA, F.MANDELLI, G.VISANI, P.PICCALUGA, E.DI BONA, R.CERRI, M.RISSO, M.E.TOSTI, VENDITTI A. (2003). Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: a comparison with the immunophenotype of 231 de novo AML. HAEMATOLOGICA. vol. 88, pp. 225-227.
88.	LO COCO F., CIMINO G, BRECCIA M, NOGUERA NI, DIVERIO D, FINOLEZZI E, POGLIANI EM, DI BONA E, MICALIZZI C, KROPP M, VENDITTI A, TAFURI A, MANDELLI F. (2004). Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia. BLOOD. vol. 104, pp. 1995-1999.
89.	LO COCO F., DIVERIO D, AVVISATI G, ET AL. (1999). Therapy of molecular relapse in acute promyelocytic leukemia. BLOOD. vol. 94, pp. 2225-2229.
90.	LO COCO F., DIVERIO D, FALINI B, BIONDI A, NERVI C, PELICCI PG. (1999). Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. BLOOD. vol. 94, pp. 12-22.
91.	LO COCO F., ZELENT A., KIMCHI A, CARDUCCI M., GORE S.D., WAXMAN S. (2002). Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. CANCER RESEARCH. vol. 62, pp. 5618-5621.
92.	LOCATELLI F., BRUNO B., ZECCA M., VAN LINT MT, MC CANN S, ARCESE W., DALLORSO S, DI BARTOLOMEO P, FAGIOLI F, LOCASCIULLI A, LAWLER M, BACIGALUPO A. (2000). Cyclosporin-A and short-term methotrexate versus cyclosporin-A as graft-versus-host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from HLA identical sibling: results of a GITMO/EBMT randomized trial. BLOOD. vol. 96, pp. 1690-1697.
93.	M. AGLIETTA, F. MONTEMURRO, F. FAGIOLI, C. VOLTA, B. BOTTO, M. CANTONETTI, V. RACANELLI, L. TEOFILI, R. FERRARA, AMADORI S., G.L. CASTOLDI, F. DAMMACCO, A. LEVIS. (2000). Short term treatment with Escheria coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease. CANCER. vol. 88, pp. 454-460.
94.	M. TRIBALTO, AMADORI S., L. CUDILLO, G. DEL POETA, G. MELONI, G. AVVISATI, M.T. PETRUCCI, A. PULSONI, G. LEONE, S. SICA, M. MARTELLI, A. TABILIO, G. FIORITONI, I. MAJOLINO, F. MANDELLI. (2000). Autologous peripheral blood stem cell transplantation first line treatment of multiple myeloma: an italian multicenter study. HAEMATOLOGICA. vol. 85, pp. 52-58.
95.	M.C. COX, P. PANETTA, F. LO-COCO, G. DEL POETA, A. VENDITTI, L. MAURILLO, M.I. DEL PRINCIPE, A. MAURIELLO, L. ANEMONA, A. BRUNO, C. MAZZONE, P. PALOMBO, AMADORI S. (2004). Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. AMERICAN JOURNAL OF CLINICAL PATHOLOGY. vol. 122, pp. 298-306.
96.	M.C.COX, P.PANETTA, A.VENDITTI, G.DEL POETA, A.FRANCHI, F.BUCCISANO, A.TAMBURINI, AMADORI S. (2003). Comparison between conventional banding analysis and FISH screening with an AML-specific set of probes in 260 patients. HEMATOLOGY JOURNAL. vol. 4, pp. 263-270.
97.	M.C.COX, P.PANETTA, VENDITTI A., E.ABRUZZESE, G.DEL POETA, M.CANTONETTI, S.AMADORI. (2001). New reciprocal translocation t(6;10)(q27;q11) associated with idiopathic myelofibrosis and eosinophilia. LEUKEMIA RESEARCH. vol. 25, pp. 249-251.
98.	M.C.COX, P.PANETTA, VENDITTI A., G.DEL POETA, L.MAURILLO, A.TAMBURINI, M.I.DEL PRINCIPE, S.AMADORI. (2003). Fluorescence in situ hybridization and conventional cytogenetics for the diagnosis of 11q23+/mll+ translocation in leukaemia. BRITISH JOURNAL OF HAEMATOLOGY. vol. 121, pp. 953-955.
99.	M.I.DEL PRINCIPE, G.DEL POETA, L.MAURILLO, F.BUCCISANO, VENDITTI A., A.TAMBURINI, A.BRUNO, M.C.COX, G.SUPPO, A.TENDAS, L.GIANN, M.POSTORINO, M.MASI, D.DEL PRINCIPE, S.AMADORI. (2003). P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY. vol. 121, pp. 730-738.
100.	MANDELLI F, LATAGLIATA R, AVVISATI G, FAZI P, RODEGHIERO F, LEONI F, GOBBI M, NOBILE F, GALLO E, FANIN R, AMADORI S., VIGNETTI M, FIORITONI G, FERRARA F, PETA A, GIUSTOLISI R, BROCCIA G, PETTI MC, LOCOCO F, ITALIAN GIMEMA COOPERATIVE GROUP. (2003). Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols. LEUKEMIA. vol. 17, pp. 1085-1090.
101.	MARCHETTI M, BAROSI G, BALESTRI F, VIARENGO G, GENTILI S, BARULLI S, DEMORY JL, ILARIUCCI F, VOLPE A, BORDESSOULE D, GROSSI A, LE BOUSSE-KERDILES MC, CAENAZZO A, PECCI A, FALCONE A, BROCCIA G, BENDOTTI C, BAUDUER F, BUCCISANO F., DUPRIEZ B. (2004). Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial. JOURNAL OF CLINICAL ONCOLOGY. vol. 22, pp. 424-431.
102.	MARTELLI M, GHERLINZONI F, DE RENZO A, ZINZANI PL, DE VIVO A, CANTONETTI M., FALINI B, STORTI S, MELONI G, RIZZO M, MOLINARI AL, LAURIA F, MORETTI L, LAUTA VM, MAZZA P, GUARDIGNI L, PESCARMONA E, PILERI SA, MANDELLI F, TURA S. (2003). Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial. JOURNAL OF CLINICAL ONCOLOGY. vol. 21, pp. 1255-1262.
103.	MASALA S, FIORI R, MASSARI F, CANTONETTI M., POSTORINO M, SIMONETTI G. (2004). Percutaneous kyphoplasty: indications and techniquein the treatment of fractures from myeloma. TUMORI. vol. 90, pp. 22-26.
104.	MASCOLO MG., DE FELICE L., TERENZI A., AGOSTINI F., FALZETTI F., DI IANNI M., PASQUALETTI D., SIMONE F., AMARANTO P., TABILIO A., ARCESE W. (2001). Early and late engraftment of short-term ex-vivo amplified human cord blood cells in NOD/SCID mice. HAEMATOLOGICA.
105.	MAURILLO L, DEL POETA G, VENDITTI A, BUCCISANO F, BATTAGLIA A, SANTINELLI S, CARAVITA T, EPICENO AM, DEL MORO B, TAMBURINI A, PICARDI A, SUPPO G, CATALANO G, BRUNO A, AMADORI S. (2001). Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors. HAEMATOLOGICA. vol. 86, pp. 237-243.
106.	MAURO FR, FOA R, MELONI G, GENTILE M, GIAMMARTINI E, GIANNARELLI D, DE PROPRIS MS, RAPANOTTI MC, DE FABRITIIS P., MANDELLI F. (2002). Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients. HAEMATOLOGICA. vol. 87(9), pp. 926-933.
107.	MELE L, RICCI P, NOSARI A, TONSO A, FIANCHI L, CUDILLO L., PAGANO L. (2002). invasive fungal infection in patients with myelodysplastic syndrome: report of twelve cases. LEUKEMIA & LYMPHOMA. vol. 43, pp. 1613-1617.
108.	MELONI G, CAPRIA S, VIGNETTI M, ALIMENA G, DE FABRITIIS P., MONTEFUSCO E, MANDELLI F. (2001). Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloyd leukemia. HAEMATOLOGICA. vol. 86(6), pp. 596-601.
109.	MELONI G, PROIA A, MAURO F, AMARANTO P, CAPRIA S, CIMINO G, CORDONE I, DE FABRITIIS P., RAPANOTTI C, REATO G, VIGNETTI M, FOA R, MANDELLI F. (2000). Unmanipulated peripheral blood stem cell autograft in chronic lymphocytic leukemia: clinical findings and biological monitoring. HAEMATOLOGICA. vol. 85(9), pp. 952-960.
110.	MENGARELLI A, MINOTTI C, PALUMBO G, ARCIERI P, GENTILE G, IORI AP, ARCESE W., MANDELLI F., AVVISATI G. (2000). High levels of anyiphospholipid antibodies are associated to CMV infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation. BRITISH JOURNAL OF HAEMATOLOGY. vol. 108, pp. 126-131.
111.	MINUCCI S, NERVI C, LO COCO F., PELICCI PG. (2001). Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias. ONCOGENE. vol. 20, pp. 3110-3115.
112.	MONTILLO M, TEDESCHI A, PAGANO L, VENDITTI A., FERRARA F, FABRIS P, MARTINO B, MUSSO M, DE ROSA G, SPECCHIA G, MONACO M, SPARAVENTI G, SPADEA A, PALMAS A, DEPLANO W, MANNA A, MELILLO L, MIRAGLIA E, MIRTO S, MANDELLI F. (2000). Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the GIMEMA Group. BRITISH JOURNAL OF HAEMATOLOGY. vol. 111, pp. 334-337.
113.	N. COOPER, R. STASI, S. CUNNINGHAM-RUNDLES, M.A. FEUERSTEIN, J.P. LEONARD, AMADORI S., J.B. BUSSEL. (2004). The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. BRITISH JOURNAL OF HAEMATOLOGY. vol. 125, pp. 232-239.
114.	NC GORIN, M LABOPIN, P ZIKOS, ARCESE W., M BEKSAC, E GLUCKMAN, O RINGDEN, T RUUTU, J REIFFERS, G BANDINI, M FALDA, R WILLEMZE, V ROCHA, F FRASSONI. ON BEHALF OF THE ACUTE LEUKAEMIA WORKING PARTY ALWP OF THE EUROPEAN COOPERATIVE GROUP FOR BLOOD AND MARROW TRANSPLANTATION EBMT. (2003). Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukaemia: influence of the dose and the source of stem cells; better outcome with rich marrow. BLOOD. pp. 3043-3051.
115.	O. RINGDEN, M. LABOPIN, A. BACIGALUPO, ARCESE W., U. W. SCHAEFER, R WILLEMZE, H. KOC, D BUNJES, E. GLUCKMAN, V. ROCHA, A. SHATTENBERG AND F. FRASSONI, FOR THE ACUTE LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION. (2002). Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. JOURNAL OF CLINICAL ONCOLOGY. vol. 24, pp. 4655-4664.
116.	OLLE RINGDN, MYRIAM LABOPIN, NORBERT-CLAUDE GORIN, KATARINA LE BLANC, VANDERSON ROCHA, ELIANE GLUCKMAN, JULES REIFFERS, WILLIAM ARCESE, JACK M. VOSSEN, JEAN-PIERRE JOUET, CATHERINE CORDONNIER AND FRANCESCO FRASSONI, ARCESE W. (2002). Increased risk of graft-versus-host disease and death using granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukaemia. JOURNAL OF CLINICAL ONCOLOGY. vol. 20, pp. 4655-4664.
117.	OOSTERVELD M, SUCIU S, VERHOEF G, LABAR B, BELHABRI A, AUL C, SELLESLAG D, FERRANT A, WIJERMANS P, MANDELLI F, AMADORI S., JEHN U, MUUS P, ZITTOUN R, HESS U, ANAK O, BEELDENS F, WILLEMZE R, DE WITTE T. (2003). The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921). LEUKEMIA. vol. 17, pp. 859-868.
118.	P DE FABRITIIS, AP IORI, A MENGARELLI, M GOZZER, G FERRAZZA, MS DE PROPRIS, ARCESE W. (2001). CD34+ cell mobilization for allogeneic progenitor cell trasplantation: efficacy of a short-course of G-CSF. TRANSFUSION. vol. 41, pp. 190-195.
119.	P. DE FABRITIIS, T. DENTAMARO, A. PICARDI, L. CUDILLO, M. MASI, AMADORI S. (2004). Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies. HAEMATOLOGICA. vol. 89, pp. 243-245.
120.	PAGANO L, GIRMENIA C, MELE L, RICCI P, TOSTI ME, NOSARI A, BUELLI M, PICARDI M, ALLIONE B, CORVATTA L, D'ANTONIO D, MONTILLO M, MELILLO L, CHIERICHINI A, CENACCHI A, TONSO A, CUDILLO L., CANDONI A, SAVIGNANO C, BONINI A, MARTINO P, DEL FAVERO A, GIMEMA INFECTION PROGRAM GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO. (2001). infection caused by filamentous fungi in patients with hematologic malignancies. a report of 391 cases by GIMEMA Infection program. HAEMATOLOGICA. vol. 86, pp. 862-870.
121.	PETRUCCI MT, AVVISATI G, LA VERDE G, DE FABRITIIS P., RIBERSANI M, PALUMBO G, DE FELICE L, RUSIGNUOLO A, SIMONE F, MELONI G, MANDELLI F. (2003). Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma. ACTA HAEMATOLOGICA. vol. 109(4), pp. 184-188.
122.	PETTI MC, FAZI F, GENTILE M, DIVERIO D, DE FABRITIIS P., DE PROPRIS MS, FIORINI R, SPIRITI MA, PADULA F, PELICCI PG, NERVI C, LO COCO F. (2002). Complete remission through blast cell differentiation in PLZF/RARalpha-positive acute promyelocytic leukemia: in vitro and in vivo studies. BLOOD. vol. 100(3), pp. 1065-1067.
123.	PH. GUARDIOLA, R. PASQUINI, I. DOKAL, M. VAN WEEL-SIPMAN, J.C.W. MARSH, S.E. BALL, F. LOCATELLI, CH. VERMYLEN, R. SKINNER, P. LJUNGMAN, R. MINIERO, P.J. SHAW, G. SOUILLET, M. MICHALLET, A.N. BEKASSY, G. KRIVAN, P. DI BARTOLOMEO, C. HEILMANN, L. ZANESCO, J.Y. CAHN, ARCESE W., A. BACIGALUPO AND E. GLUCKMAN FOR THE SEVERE APLASTIC ANEMIA WORKING PARTY OF THE EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP AND EUFAR. (2000). Outcome of 69 allogeneic stem cell transplantations for Fanconi Anemia patients using HLA-matched unrelated donors. A study on behalf of the European Group for Blood and Marrow Transplantation. BLOOD. vol. 95, pp. 422-429.
124.	PICARDI A., DE FABRITIIS P, CUDILLO P, DENTAMARO T, CUPELLI L, BALLATORE G, VENDITTI G, CAROVITA T, COX MC, CATALANO G, AMADORI S. (2004). PossibilitY of long term remission in patients with hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation. HEMATOLOGY JOURNAL.
125.	PICARDI A., DEL PRINCIPE D, CUDILLO L, DENTAMARO T, AMADORI S, DE FABRITIIS P. (2004). Unrelated cord blood transplantation for children with high risk myelodysplastic syndromes. HAEMATOLOGICA (PAVIA).
126.	R RAIMONDI, M SOLI, T LAMPARELLI, A BACIGALUPO, ARCESE W., M BELLONI, F RODEGHIERO. (2004). ABO incompatibile Bone Marrow Transplantation: a GITMO survey of current practice in Italy and comparison with the literature. BONE MARROW TRANSPLANTATION. vol. 34, pp. 321-329.
127.	R. STASI, AMADORI S., A.C. NEWLAND, D. PROVAN, N. CASADEVALL, P. DURIEUX, F. DREYFUS, P. FENAUX. (2004). Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges. BLOOD. vol. 104, pp. 2201-2202.
128.	R. STASI, M. BRUNETTI, E. STIPA, AMADORI S. (2004). Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. BLOOD. vol. 103, pp. 4424-4428.
129.	R.BELLUCCI, MS DE PROPIS, BUCCISANO F., A.LISCI, G.LEONE, A.TABILIO, P.DE FABRITIIS. (1999). Modulation of VLA-4 and L-selectin expression on normal CD34+ cells during mobilization with G-CSF. BONE MARROW TRANSPLANTATION. vol. 23, pp. 1-8.
130.	R.STASI, VENDITTI A., G.DEL POETA, F.BUCCISANO, L.MAURILLO, I.DEL PRINCIPE, A.RICCITELLI, A.BRUNO, M.C.COX-FRONCILLO, S.AMADORI. (1999). AML-M0: A review of laboratory features and proposal of new diagnostic criteria. BLOOD CELLS MOLECULES AND DISEASES. vol. 8, pp. 120-129.
131.	ROCHA V., CORNISH EL., SIEVERS A., FILIPOVICH A., LOCATELLI F., PETERS C., REMBERGER M., MICHEL G., ARCESE W., DALLORSO S., TIEDEMANN K., BUSCA A. (2001). Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. BLOOD. vol. 97, pp. 2962-2971.
132.	ROCHA V., LABOPIN M., GLUCKMAN E., POWELS R., ARCESE W., BACIGALUPO A., REIFFERS J., IRIONDO A., RINGDEN O., RUUTU T., FRASSONI F. (2002). Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. JOURNAL OF CLINICAL ONCOLOGY. vol. 20, pp. 4324-30.
133.	ROZOVSKA T, RAVID AMIR O, TILLIB S, GETZ G, FEINSTEIN E, AGRAWAL H, NAGLER A, RAPPAPORT EF, ISSAEVA I, MATSUO Y, KEES UR, LAPIDOT T, LO COCO F, FO R, MAZO A, NAKAMURA T, CROCE CM, CIMINO G., DOMANY E, CANAANI E. (2003). Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. vol. 100, pp. 7853-7858.
134.	ROZVOSKAIA T, FEINSTEIN E, MOR O, FO R, BLECHAMAN J, NAKAMURA T, CROCE CM, CIMINO G., CANAANI E. (2001). Upregulation of MEIS1 and HoxA9 in acute lymphoblastic leukemia with the t(4;11) abnormality. ONCOGENE. vol. 20, pp. 874.
135.	SCONOCCHIA G, CAMPAGNANO L, ADORNO D, IACONA A, COCOCCETTA NY, BOFFO V, AMADORI S., CASCIANI CU. (2001). CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. BLOOD. vol. 97, pp. 3621-3627.
136.	SCONOCCHIA G, COCOCCETTA NY, CAMPAGNANO L, AMADORI S., IORIO B, BOFFO V, FERDINANDI V, DEL PRINCIPE I, ADORNO D, CASCIANI CU. (2001). Subcutaneous administration of interleukin-2 triggers Fcgamma receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies. JOURNAL OF IMMUNOTHERAPY. vol. 24, pp. 374-383.
137.	SERRANO J, LO COCO F, SPROVIERI T, ELIA L, VITALE A, GREGORJ C, TAFURI A, SANCHEZ J, ROMAN J, TORRES A, CIMINO G. (2000). Myeloperoxidase gene expression in non infant pro-B acute lymphoblastic leukemia with or without ALL1/AF4 transcript. BRITISH JOURNAL OF HAEMATOLOGY. vol. 111, pp. 1065.
138.	STASI R, AMADORI S. (2002). Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes. BRITISH JOURNAL OF HAEMATOLOGY. vol. 116, pp. 334-337.
139.	STASI R, AMADORI S. (2002). The role of angiogenesis in hematologic malignancies. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. vol. 11, pp. 49-68.
140.	STASI R, BRUNETTI F, PAGANO A, STIPA E, MASI M, AMADORI S. (2000). Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura. BLOOD CELLS MOLECULES AND DISEASES. vol. 6, pp. 582-586.
141.	STASI R, BRUNETTI M, TERZOLI E, AMADORI S. (2002). Sustained response to recombinant human erytropoietin and intermittent all-trans retinoic acid in patients with myelodysplastic syndromes. BLOOD. vol. 99, pp. 1578-1584.
142.	STASI R, PAGANO A, STIPA E, AMADORI S. (2001). Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. BLOOD. vol. 98, pp. 952-957.
143.	STASI R, STIPA E, FORTE V, MEO P, AMADORI S. (2002). Variable patterns of response to rituximab treatment in adults with chronic thrombocytopenic purpura. BLOOD. vol. 99, pp. 3872-3873.
144.	SUCIU S, MANDELLI F, DE WITTE T, ZITTOUN R, GALLO E, LABAR B, DE ROSA G, BELHABRI A, GIUSTOLISI R, DELARUE R, LISO V, MIRTO S, LEONE G, BOURHIS JH, FIORITONI G, JEHN U, AMADORI S., FAZI P, HAGEMEIJER A, WILLEMZE R, EORTC AND GIMEMA LEUKEMIA GROUPS. (2003). Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. BLOOD. vol. 102, pp. 1232-1240.
145.	TAFURI A, GREGORJ C, PETRUCCI MT, RICCIARDI MR, MANCINI M, CIMINO G. (2002). MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. BLOOD. vol. 100, pp. 974.
146.	V. ROCHA, J. CORNISH, E.L. SIEVERS, A. FILIPOVICH, F. LOCATELLI, C. PETERS, M. REMBERGER, G. MICHEL, ARCESE W., S. DALLORSO, K. TIEDEMANN, A. BUSCA, K-W. CHAN, S. KATO, J. ORTEGA, M. VOWELS, A. ZANDER, G. SOUILLET, A. OAKILL, A. WOOLFREY, A.L. PAY, A.GREEN, F. GARNIER, I. IONESCU, P. WERNET, G. SIRCHIA, P. RUBINSTEIN, S. CHEVRET AND E. GLUCKMAN. (2001). Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. BLOOD. vol. 97, pp. 2962-2971.
147.	VANDERSON ROCHA, MYRIAM LABOPIN, ELIANE GLUCKMAN, RAY POWLES WILLIAM ARCESE, ANDREA BACIGALUPO, JOSY REIFFERS, ALBERTO IRIONDO, OLLE RINGDN, ARCESE W. (2002). Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. JOURNAL OF CLINICAL ONCOLOGY. vol. 20, pp. 4324-4330.
148.	VANDERSON ROCHA, MYRIAM LABOPIN, GUILLERMO SANZ, WILLIAM ARCESE, RAINER SCHWERDTFEG, ALBERTO BOSI, NIELS JACOBSEN, TAPANI RUUTU, MARCOS DE LIMA, JURGEN FINKE, FRANCESCO FRASSONI, ELIANE GLUCKMAN, ARCESE W. (2004). Comparison Of Outcomes After Unrelated Umbilical Cord Blood Versus Unrelated Bone Marrow Transplants In Adults With Acute Leukemia. THE NEW ENGLAND JOURNAL OF MEDICINE*.
149.	VENDITTI A, BATTAGLIA A, DEL POETA G, BUCCISANO F, MAURILLO L, TAMBURINI A, DEL MORO B, EPICENO AM, MARTIRADONNA M, CARAVITA T, SANTINELLI S, ADORNO G, PICARDI A, ZINNO F, LANTI A, BRUNO A, SUPPO G, FRANCHI A, FRANCONI G, AMADORI S. (1999). Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods. BONE MARROW TRANSPLANTATION. vol. 24, pp. 1019-1027.
150.	VENDITTI A, BUCCISANO F., DEL POETA G, MAURILLO L, TAMBURINI A, COX C, BATTAGLIA A, CATALANO G, DEL MORO B, CUDILLO L, POSTORINO M, MASI M, AMADORI S. (2000). Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. BLOOD. vol. 96, pp. 3948-3952.
151.	VENDITTI A, DEL POETA G, MAURILLO L, BUCCISANO F., DEL PRINCIPE MI, MAZZONE C, TAMBURINI A, COX C, PANETTA P, NERI B, OTTAVIANI L, AMADORI S. (2004). Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia. HAEMATOLOGICA. vol. 89, pp. 934-939.
152.	VENDITTI A, MAURILLO L, BUCCISANO F, TAMBURINI A, DEL POETA G, DEL PRINCIPE MI, PANETTA P, CONSALVO MI, MAZZONE C, TENDAS A, TRAWINSKA M, FORTE V, AMADORI S. (2002). Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia. LEUKEMIA & LYMPHOMA. vol. 44, pp. 445-450.
153.	VENDITTI A, MAURILLO L, BUCCISANO F., DEL POETA G, MAZZONE C, TAMBURINI A, DEL PRINCIPE MI, CONSALVO MI, DE FABRITIIS P, CUDILLO L, PICARDI A, FRANCHI A, LO-COCO F, AMADORI S, LO COCO F. (2003). Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation. LEUKEMIA. vol. 17, pp. 2178-2182.
154.	VENDITTI A, MAURILLO L, BUCCISANO F., TAMBURINI A, DEL POETA G, DEL PRINCIPE MI, PANETTA P, CONSALVO MI, MAZZONE C, TENDAS A, TRAWINSKA M, FORTE V, AMADORI S. (2003). MULTIDIMENSIONAL FLOW CYTOMETRY FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA. LEUKEMIA & LYMPHOMA. vol. 44, pp. 445-450.
155.	VENDITTI A, TAMBURINI A, BUCCISANO F., DEL POETA G, MAURILLO L, PANETTA P, SCORNAJENGHI KA, COX C, AMADORI S. (2002). Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH. vol. 11, pp. 349-357.
156.	VENDITTI A., TAMBURINI A, BUCCISANO F, SCIMÒ MT, DEL POETA G, MAURILLO L, COX MC, ABRUZZESE E, TRIBALTO M, MASI M, AMADORI S. (2000). A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes. ANNALS OF HEMATOLOGY. vol. 79, pp. 138-142.
157.	WILLIAM ARCESE, ADELMO TERENZI, MARIA GRAZIA MASCOLO, FRANCESCA AGOSTINI, FRANCA FALZETTI, MARIA SCRENCI, MAURO DI IANNI, DANIELA PASQUALETTI, ARCESE W. (2002). Kinetic Of Engraftment In Nod/Scid Mice Transplanted With Ex-Vivo Short-Term Culture Amplified Human Cord Blood Cells. A Model For The Clinical Setting. Proceedings of the 2° EBMT Workshop. (pp. 39-46).
158.	WILLIAM ARCESE, ANNA PAOLA IORI, MARIA SCRENCI, ANDREA ROVEDA, RAFFAELLA CERRETTI, ARCESE W. (2003). Trapianto di Cellule staminali Ematopoietiche da Sangue di Cordone Ombelicale. Associazione Nazionale Immunogenetica e Biologia dei Trapianti.
159.	WILLIAM ARCESE, LIDIA DE FELICE, MARIA SCRENCI, ANDREA MENGARELLI, ANNA MARIA TESTI, ATELDA ROMANO, MARIA LUISA MOLETI, RAFFAELLA CERRETTI, FIORINA GIONA, IRENE PASQUA, ARCESE W. (2002). Trapianto di Cellule Staminali Ematopoietiche da Sangue di Cordone Ombelicale. I Convegno ADISCO- Abbazia di Spineto, 7-8 Novembre. (pp. 21-27).
160.	ZINZANI PL, MAGAGNOLI M, GALIENI P, MARTELLI M, POLETTI V, ZAIA F, ZACCARIA A, CANTONETTI M., GENTILINI P, GUARDIGNI L, GHERLINZONI F, RIBERSANI M. (1999). Non-gastrointestinal low grade mucosa associated lymphoid tissue lymphoma: analysis of 75 patients. JOURNAL OF CLINICAL ONCOLOGY. vol. 17(4), pp. 1254-1258.
161.	ZINZANI PL, MARTELLI M, BERTINI M, GIANNI AM, DEVIZZI L, FEDERICO M, PANGALIS G, MICHELS J, ZUCCA E, CANTONETTI M., CORTELAZZO S, WOTHERSPOON A, FERRERI AJ, ZAJA F, LAURIA F, DE RENZO A, LIBERATI MA, FALINI B, BALZAROTTI M, CALDERONI A, ZACCARIA A, GENTILINI P, FATTORI PP, PAVONE E, ANGELOPOULOU MK, ALINARI L, BRUGIATELLI M, DI RENZO N, BONIFAZI F, PILERI SA, CAVALLI F. (2002). Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. HAEMATOLOGICA. vol. 87, pp. 1258-1264.